Business, energy, technology, markets and global industry news from Business News Today

HeartBeam Inc.

PharmaDeviceNews HeartBeam Inc.
Infographic showing HeartBeam’s 132-patient acute coronary syndrome pilot, highlighting higher specificity, comparable sensitivity to a standard 12-lead ECG, clinically supervised recordings and the investigational status of its heart attack assessment function.
Medical Devices & Diagnostics

HeartBeam 3D ECG achieves 81.8% specificity in 132-patient heart attack study, beating standard ECG on one measure

HeartBeam has reported higher specificity and comparable sensitivity to a standard 12-lead ECG in a 132-patient acute coronary syndrome pilot. However, the recordings were made under clinical supervision, and the device's heart attack assessment function remains investigational ahead of a planned US pivotal study.

Read More
Representative image of a patient using a portable ECG device during a remote cardiac consultation, illustrating how HeartBeam’s technology could move heart attack risk assessment closer to the patient.
Medical Devices & Diagnostics

HeartBeam’s peer-reviewed ECG data raises the stakes in remote cardiac diagnostics

HeartBeam’s ECG evidence could push chest pain assessment closer to patients. The next test is FDA clarity and clinical trust.

Read More